Literature DB >> 30112696

A method for expansion of T cells from cynomolgus monkey (Macaca fascicularis).

Change Gao1, Qian Song2, Ming Zhang3, Jian Li4, Miao Yi2, Jian Dong5.   

Abstract

T cells have been successfully applied to cancer immunotherapy. However, a challenge is an expansion of T cells from cynomolgus monkey, which is a valuable non-human primate model for T cell therapy transferring to the clinic. Here, we compared several strategies to expand cynomolgus monkey T cell and developed an appropriate method. Our study demonstrated that 100 ng/ml CD3 mAb + 1% PHA+ 1000 U/ml IL2 therapy significantly expanded peripheral blood CD3+ T cells without compromising T cell phenotype in vitro. The results of this study could be used for T cell remodeling, which has significant therapeutic potential in Chimeric Antigen Receptor-T (CAR-T) cell immunotherapy.

Entities:  

Keywords:  Immunotherapy; Non-human primate model; Stimulation strategy

Mesh:

Year:  2018        PMID: 30112696     DOI: 10.1007/s11626-018-0278-y

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  19 in total

1.  In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

Authors:  Dela Golshayan; Shuiping Jiang; Julia Tsang; Marina I Garin; Christian Mottet; Robert I Lechler
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

2.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

3.  Human in vivo-activated CD45R0(+) CD4(+) T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2, -6, -7, and -15.

Authors:  Mervi Pajusto; Niina Ihalainen; Jukka Pelkonen; Jussi Tarkkanen; Petri S Mattila
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

4.  Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation.

Authors:  Hong Shen; Tongtong Liu; Hao Jiang; Craig Titsch; Kristin Taylor; Hamza Kandoussi; Xi Qiu; Cliff Chen; Sunil Sukrutharaj; Kathy Kuit; Gabe Mintier; Prasad Krishnamurthy; R Marcus Fancher; Jianing Zeng; A David Rodrigues; Punit Marathe; Yurong Lai
Journal:  Drug Metab Dispos       Date:  2015-11-25       Impact factor: 3.922

5.  Surgical and psychological stressors differentially affect cytolytic responses in the rhesus monkey.

Authors:  A M Lemieux; C L Coe; W B Ershler; J W Karaszewski
Journal:  Brain Behav Immun       Date:  1996-03       Impact factor: 7.217

6.  Characterization of natural killer cells in tamarins: a technical basis for studies of innate immunity.

Authors:  Tomoyuki Yoshida; Akatsuki Saito; Yuki Iwasaki; Sayuki Iijima; Terue Kurosawa; Yuko Katakai; Yasuhiro Yasutomi; Keith A Reimann; Toshiyuki Hayakawa; Hirofumi Akari
Journal:  Front Microbiol       Date:  2010-12-08       Impact factor: 5.640

7.  In vivo safety and persistence of endoribonuclease gene-transduced CD4+ T cells in cynomolgus macaques for HIV-1 gene therapy model.

Authors:  Hideto Chono; Naoki Saito; Hiroshi Tsuda; Hiroaki Shibata; Naohide Ageyama; Keiji Terao; Yasuhiro Yasutomi; Junichi Mineno; Ikunoshin Kato
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

8.  Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.

Authors:  Marcus O Butler; Osamu Imataki; Yoshihiro Yamashita; Makito Tanaka; Sascha Ansén; Alla Berezovskaya; Genita Metzler; Matthew I Milstein; Mary M Mooney; Andrew P Murray; Hiroyuki Mano; Lee M Nadler; Naoto Hirano
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

Review 9.  Genetically modified T cells in cancer therapy: opportunities and challenges.

Authors:  Michaela Sharpe; Natalie Mount
Journal:  Dis Model Mech       Date:  2015-04-01       Impact factor: 5.758

10.  Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement.

Authors:  Corey Smith; Grethe Økern; Sweera Rehan; Leone Beagley; Sau K Lee; Tanja Aarvak; Karoline W Schjetne; Rajiv Khanna
Journal:  Clin Transl Immunology       Date:  2015-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.